Previous 10 | Next 10 |
Myomo, Inc. (MYO) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Vivian Cervantes – Investor Relations Paul Gudonis – Chairman and Chief Executive Officer David Henry – Chief Financial Officer Conference Call Participants ...
Myomo (NYSEMKT: MYO ): Q4 GAAP EPS of -$0.22 beats by $0.03 . More news on: Myomo, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Reports Record Revenues and Reimbursement Pipeline for the Fourth Quarter and Full Year Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...
Management to hold a conference call at 4:30 p.m. EST Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralys...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today has closed its previously announced underwritten pu...
Gainers: eGain Corporation (NASDAQ: EGAN ) +41% . Coty (NYSE: COTY ) +28% . Mattel (NASDAQ: MAT ) +24% . Sanchez Midstream Partners LP (NYSEMKT: SNMP ) +18% . Forum Energy Technologies (NYSE: FET ) +18% . Aceto (NASDAQ: ACET ) +16% . Omnicell (NASDAQ: OMCL ) +16% . Columbia Sp...
MagneGas Applied Technology Solutions (NASDAQ: MNGA ) -46% . More news on: MagneGas Corporation, Cellect Biotechnology Ltd., Biocept, Inc., Stocks on the move, Read more ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of its previously announced u...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is proposing to offer and sell, s...
Myomo Inc. (NYSE American MYO) (“Myomo,” or the “Company”), a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Of...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...